Biotricity, Inc.

Equities

BTCY

US09074H2031

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Other stock markets 02:00:00 23/05/2024 am IST			5-day change	1st Jan Change
1.24 ^USD	+12.73%		+8.77%	+7.83%

26/04	Biotricity Inc. Announces High Demand for Its Latest Device, Biotres Pro	CI
19/04	Top Premarket Decliners	MT

Biotricity, Inc. Announces Earnings Guidance for the Fiscal 2022

June 18, 2021 at 01:58 am IST

Biotricity, Inc. announced earnings guidance for the fiscal 2022. The company expects to easily beat fourth quarter revenue in current quarter ending June 30, 2021 and are targeting triple digit revenue growth for fiscal 2022.

Latest news about Biotricity, Inc.

Biotricity Inc. Announces High Demand for Its Latest Device, Biotres Pro	26/04	CI
Top Premarket Decliners	19/04	MT
Biotricity, Inc. announced that it has received $2 million in funding	09/04	CI
Biotricity Announces Strategic Partnership for Cardiac Screenings in Patients with Co-Morbidities	02/04	CI
Biotricity, Inc. announced a financing transaction	25/03	CI
Biotricity Unveils That Improved Margins Resulted from Latest Advancements to Its Proprietary Cardiac Ai Cloud Platform and Announces Plans for Continued Expansion of Its Cardiac AI Cloud	12/03	CI
Biotricity, Inc. Solidifies It's Presence in the Healthcare Landscape	05/03	CI
Transcript : Biotricity, Inc., Q3 2024 Earnings Call, Feb 21, 2024	22/02
Biotricity, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	21/02	CI
Biotricity Inc. Expands Development of its Cardiac AI Cloud Platform with Data Ecosystem of over 360 Billion Heartbeats	23/01	CI
HC Wainwright Downgrades Biotricity to Neutral From Buy	20/11	MT
Transcript : Biotricity, Inc., Q2 2024 Earnings Call, Nov 14, 2023	15/11
Biotricity, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	15/11	CI
Biotricity Releases Another Groundbreaking Product: Biotres Pro	31/23/31	CI
Biotricity Files Patent for Wearable Heart Monitoring Device Bioheart	10/23/10	MT
Biotricity Continues to Expand Patent Portfolio with Latest Patent Filing for Bioheart Device	10/23/10	CI
Biotricity, Inc. Announces Patent Filing for Cutting-Edge Biotres Device	03/23/03	CI
Transcript : Biotricity, Inc., Q1 2024 Earnings Call, Aug 15, 2023	16/23/16
Biotricity, Inc. Reports Earnings Results for the First Quarter Ended June 30, 2023	15/23/15	CI
Biotricity Expands Amazon, Google Partnership for Remote Cardiac Monitoring Technology	25/23/25	MT
Biotricity Inc. Expands Its Proprietary AI Model and Deepens Relationship with Amazon Aws and Google's Tensor Flow for Remote Cardiac Care Applications	25/23/25	CI
HC Wainwright Adjusts Biotricity Price Target to $4 From $12 After 1-for-6 Reverse Stock Split, Maintains Buy Rating	07/23/07	MT
Biotricity, Inc. Provides Earnings Guidance for the First Fiscal Quarter Ended June 30, 2023	06/23/06	CI
HC Wainwright Adjusts Biotricity Price Target to $4 From $12, Maintains Buy Rating	05/23/05	MT
Monday's Top Decliners	03/23/03	MT

Chart Biotricity, Inc.

Duration

Period

More charts

Company Profile

Biotricity Inc. is a medical technology company focused on biometric data monitoring and diagnostic solutions. The Company developed its Bioflux technology, comprised of a monitoring device and software components. The Bioflux device is comprised of a wet electrode worn on a belt clip around the waist. The Bioflux ECG reporting software enables doctors and labs to view a patientâs electrocardiogram (ECG) data for monitoring and diagnostic purposes. Its Bioflux platform has a built-in cellular chipset and a real-time embedded operating system, which allows for its technology to be utilized as an Internet of Things (IoT) platform. It has developed several technologies, including Biotres, Bioheart, and Biocare. Biotres is an ECG Holter solution that addresses the limitations of existing solutions in the Holter market. Bioheart is a personal cardiac monitoring solution for consumers. Biocare is a cardiac disease management platform for chronic care management and remote patient monitoring.

Sector

Advanced Medical Equipment & Technology

Calendar

20/06/2024 - Q4 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

1.24

Average target price

Consensus

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Monitoring Systems

	1st Jan change	Capi.
BIOTRICITY, INC.	+7.83%	14.33M
IRHYTHM TECHNOLOGIES, INC.	-15.37%	2.82B
EKF DIAGNOSTICS HOLDINGS PLC	+1.67%	188M
MEDIANA CO.,LTD	-17.50%	80.71M
NEUROTECH INTERNATIONAL LIMITED	+10.14%	50.66M

Medical Monitoring Systems